Mayo Clinic Health System expanding efforts to detect breast cancer earlier with MBI testing

Mayo Clinic Health System is comparing its Molecular Breast Imaging technology with the medical field’s standard 3D imaging’s ability to detect potential tumors.

MBI allows doctors to better see through the tissue of women with denser breasts.

One patient in the program had stage 1 breast cancer detected and was able to recover after surgery and oral medication.

“We were not able to see that tumor on a 3D mammogram, and we likely wouldn’t have been able to see that for three or four years. Which is kind of scary as a woman, thinking about a tumor in your body and not being able to detect it,” said Carolyn Flock, the program manager of research operations in southwest Wisconsin at Mayo.

Since beginning these trials in 2017, Mayo’s La Crosse hospital has found seven cancers among more than 390 study participants. Four of those were not detected by standard 3D imaging.

Get your weather forecast from people that actually live in your community. We update with short, easy-to-use video forecasts you can watch on your phone every day. Download the iOS or Android app here.